Patient info Open main menu

Dopamine hydrochloride 40 mg/ml concentrate for solution for infusion – patient leaflet, side effects, dosage

Last updated: · Text from the MHRA, as of · About this document

Medicine status: Prescription only (POM) Details

Medicine strength:
40 mg / ml
Contains active substance:
ATC code:

Patient leaflet - Dopamine Hydrochloride 40 mg / ml concentrate for solution for infusion

1. What Dopamine Concentrate is and what it is used for

Dopamine Concentrate contains dopamine hydrochloride which helps to increase the strength of muscle contraction in the heart.

It is used in adults:

  • to treat low blood pressure or shock (reduction of blood flow through the body tissues) after a heart attack, blood poisoning, trauma (injury) or kidney failure
  • in combination with other treatments where low blood pressure occurs after open heart surgery
  • in congestive heart failure (heart failure due to a build-up of fluid/blood).

2. What you need to know before you are given Dopamine Concentrate

Do not use Dopamine Concentrate

  • If you are allergic to dopamine hydrochloride or any other ingredients of this medicine (listed in section 6).
  • If you have a tumour that causes an increase in blood pressure.
  • If you have irregular or rapid heartbeats.
  • If you have an overactive thyroid gland

Warnings and precautions

Talk to your doctor, pharmacist or nurse before using Dopamine Concentrate if:

  • you have any heart related problems
  • you have a weaker pulse in your wrists than normal on examination
  • If you have a history of blood circulation problems (you will be monitored for any changes in colour or temperature of your fingers or toes)
  • you know that you are suffering or have suffered from problems related to circulation of blood in your hands and feet (peripheral vascular disease)
  • If you have any kidney or liver diseases
  • If you have diabetes

If possible, tell your doctor if any of the above applies to you before this medicine is used.

Children

The safety and efficacy of Dopamine Concentrate in children has not been established.

Other medicines and Dopamine Concentrate

Tell your doctor if you are taking, have recently taken or might take any other medicines, for example:

  • Monoamine oxidase inhibitors (anti-depressant medicine)
  • Anaesthetics (dopamine must not be used with cyclopropane and halogenated hydrocarbon anaesthetics)
  • Alpha- and beta-blockers, e.g. propranolol (medicines which are often used for treating blood pressure and heart disorders)
  • Phenytoin (a medicine used to treat epilepsy)

Fertility, pregnancy and lactation

If you are pregnant or breast-feeding, think you may be pregnant or are planning to have a baby, ask your doctor or pharmacist for advice before taking this medicine.

Driving and using machines

Do not drive or use machines if you experience any side effects (e.g. dizziness or difficulty seeing in bright light) which may lessen your ability to do so.

Dopamine Concentrate contains:

This medicine contains potassium metabisulfite (E224); which may rarely cause severe hypersensitivity reactions and bronchospasm.

This medicine contains less than 1 mmol (39 mg) potassium per ampoule i.e. it is essentially ‘potassium-free’.

This medicine contains less than 1 mmol (23 mg) of sodium per ampoule, i.e. it is essentially ‘sodium-free’.

3. How Dopamine Concentrate is given to you

This medicine will be diluted before it is given to you. It will be given as an infusion (drip) into a vein.

Dose

If your blood volume is low, you may be given a transfusion of blood or a plasma expander before dopamine is given.

Your doctor will work out the recommended dose of dopamine for you and how often it must be given. The dose will depend upon your medical condition and your size.

The rate of administration will be carefully controlled and adjusted according to your response. During treatment your heart rate, blood pressure and urine output will be measured to check how you are responding.

Dopamine 40 mg/ml Sterile Concentrate

The following information is intended for medical or healthcare professionals only

Further to the information included in section 3, practical information on the preparation/ handling of the medicinal product is provided here.

Incompatibilities

Dopamine Concentrate should not be added to any alkaline intravenous solutions, i.e. sodium bicarbonate. Any solution which exhibits physical or chemical incompatibility through a colour change or precipitate should not be administered.

It is suggested that admixtures containing gentamicin sulfate, cephalothin sodium, cephalothin sodium neutral or oxacillin sodium should be avoided unless all other viable alternatives have been exhausted.

Admixtures of ampicillin and dopamine in 5% glucose solution are alkaline and incompatible and result in decomposition of both drugs. They should not be admixed.

Admixtures of dopamine, amphotericin B in 5% glucose solution are incompatible as a precipitate forms immediately on mixing.

Special precautions for disposal and handling

For single use. Any unused medicinal product or waste material should be disposed of in accordance with local requirements.

Do not use if the solution is discoloured.

JFIDOPA5BW NO-6410BA3 r0 Piz If you use more Dopamine Concentrate than you should

This medicine will be given to you in a hospital, under the supervision of a doctor. It is unlikely that you will be given too much or too little, however, tell your doctor or nurse if you have any concerns.

If you have any further questions on the use of this medicine, ask your doctor, pharmacist or nurse.

4. Possible side effects

Like all medicines Dopamine Concentrate can cause side effects, although not everybody gets them.

If any of the following happen, tell your doctor immediately:

Uncommon:

  • severe allergic reaction - you may experience a sudden itchy rash (hives), swelling of the hands, feet, ankles, face, lips, mouth or throat (which may cause difficulty in swallowing or breathing), and you may feel you are going to faint
  • pain or poor circulation in your fingers or toes (you may notice a change in skin colour even to black) (gangrene)
  • pain or swelling at the injection site during or immediately after the injection
  • severe palpitations

These are serious side effects. You may need urgent medical attention.

If any of the following happen, tell your doctor as soon as possible:

Common:

  • irregular, rapid or slow heart beats
  • chest pain
  • shortness of breath
  • low blood pressure (you may feel dizzy or faint, particularly when standing up or getting out of bed)
  • narrowing of blood vessels (which may cause the skin to become cold and to turn pale or to have a bluish colour)
  • feeling or being sick
  • headache

Uncommon:

  • high blood pressure (you may get headaches or your doctor may monitor for this)
  • abnormalities in the ECG (a tracing of electrical currents in the heart)
  • dilation of the pupil of the eye (mydriasis) which may cause difficulty seeing in bright light
  • goose pimples

Dopamine may lead to changes in your blood chemistry. Your doctor may take blood samples to monitor for these.

Reporting of side effects

If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via the Yellow Card System at: www.mhra.gov.uk/yellowcard or search for MHRA Yellow Card in the Google Play or Apple App Store.

By reporting side effects you can help provide more information on the safety of this medicine

5. How to store Dopamine Concentrate

Keep this medicine out of the sight and reach of children.

Do not use this medicine after the expiry date which is stated on the ampoule and carton after ‘EXP’. When only a month and year is stated the expiry date refers to the last day of that month.

Store in the original package to protect the product from light. Do not freeze. Prepared infusions should be used immediately, however, if this is not possible they can be stored for up to 24 hours provided they have been prepared in a way to exclude microbial contamination. Do not use this medicine if you notice an opaque, cloudy or discoloured solution.

6. Contents of the pack and other information

What Dopamine Concentrate contains

The active substance is dopamine hydrochloride.

Each millilitre (ml) of concentrate contains 40 milligrams (mg) of dopamine hydrochloride. The other ingredients are potassium metabisulfite (E224), sodium chloride, water for injections, sodium hydroxide (for pH-adjustment) and hydrochloric acid (for pH-adjustment).

What Dopamine Concentrate looks like and contents of pack

The solution should be clear and colourless or pale brownish-yellow in a glass ampoule Each ampoule contains 200 mg dopamine hydrochloride.

There are 5 ampoules packed in a cardboard box.

Marketing authorisation holder

S.A.L.F. S.p.A. Laboratorio Farmacologico via Marconi, 2 - 24069 Cenate Sotto (BG) Italy

Manufacturer

S.A.L.F. S.p.A. Laboratorio Farmacologico via G. Mazzini, 9 - 24069 Cenate Sotto (BG) Italy

This leaflet was last revised in 08/2024.

Preparation of Infusion Solutions

Dilution:

Aseptically transfer the sterile concentrate into the IV solution as shown in the following table:

Strength of ConcentrateVolume of concentrate (ml)IV Solution Volume (ml)Final Concentration (microgram/ml)
200 mg/5 ml5500400
200 mg/5 ml5250800
200 mg/5 ml102501600
200 mg/5 ml205001600

Dopamine hydrochloride can be diluted with:

  • Sodium chloride (0.9%) intravenous infusion
  • Dextrose (5%), sodium chloride (0.45%) solution
  • Ringer lactate

Laboratory test interferences

Infusion of dopamine suppresses pituitary secretion of thyroid stimulating hormone, and prolactin.

In-use Shelf life

Following dilution in the recommended diluents, chemical and physical in use stability has been demonstrated for 24 hours at a temperature not above 25°C.

However, from a microbiological point of view, the product should be used immediately. If not used immediately, in use storage times and conditions prior to use are the responsibility of the user and would normally not be longer than 24 hours at 2-8 °C unless dilution has taken place in controlled and validated aseptic conditions.

About this document

Source: MHRA - Medicines and Healthcare products Regulatory Agency (products.mhra.gov.uk) · Marketing authorisation: PL 29472/0004

Last revision stated in the text: August 2024 · MHRA data as of 13 October 2026

Found a mistake? Tell us on the contact page.

The information on this site does not replace the advice of a doctor or pharmacist.

Facts about Dopamine Hydrochloride 40 mg / ml concentrate for solution for infusion

Prescription needed? Yes, prescription-only medicine (POM)
Active substance Dopamine
Strength 40 mg / ml
Pharmaceutical form Solution for infusion
A clear, colourless or pale brownish-yellow solution.
How is it taken Intravenous
Excipients Potassium Metabisulfite (E224), Sodium Chloride, Sodium hydroxide (for pH-adjustment), Hydrochloric acid (for pH-adjustment), Water for Injections
Is it available? Listed as available (NHS Dictionary of Medicines and Devices – not a record of current supplies)
Shelf life 36 months.
Following dilution in the recommended diluents (see section 6.6), chemical and physical in-use stability has been demonstrated for 24 hours at 25°C. From a microbiological point of view, the product should be used immediately. If not used immediately, in-use storage times and conditions prior to use are the responsibility of the user and would normally not be longer than 24 hours at 2-8°C unless dilution has taken place in controlled and validated aseptic conditions.’
Storage Store in the original package to protect the product from light. No special storage conditions in relation to temperature. Do not freeze.
For storage conditions after dilution of the medicinal product, see section 6.3.
Drug group (ATC) Adrenergic and dopaminergic agents
  1. C Cardiovascular system drugs
    1. C01 Cardiac therapy drugs
      1. C01C Cardiac stimulants excl. cardiac glycosides
        1. C01CA Adrenergic and dopaminergic cardiac stimulants
          1. C01CA04 dopamine
Marketing authorisation PL 29472/0004 (first authorised 2 October 2024)
Marketing authorisation holder S.A.L.F. S.p.A. Laboratorio Farmacologico
Codes BNF 02070100

Sources: the MHRA product information (products.mhra.gov.uk) and the NHS Dictionary of Medicines and Devices (dm+d), release 10.1.0 of 12 October 2026, NHS Business Services Authority. Contains public sector information licensed under the Open Government Licence v3.0.